Key result
Chest pain centre accreditation was associated with lower in-hospital mortality (OR 0.70; 95% CI 0.53-0.93) and increased PCI usage among patients with acute coronary syndrome.
Why the study?
Large-scale real-world data evaluating the impact of chest pain centre accreditation on ACS emergency care in heavy-burden developing countries like China were rare.
Does chest pain centre accreditation improve in-hospital mortality and management in patients with acute coronary syndrome?
Population
798 008 patients with ACS from 746 hospitals
Comparison
Hospitals with vs without CPC accreditation, and before vs after accreditation
Design
Retrospective propensity score-matched and longitudinal self-contrast study
Authors
Loading...
May inform ACS centre accreditation standards; leaves open causal benefits pending randomized confirmation.
Observational (n=798,008)
Yes
Does chest pain centre accreditation improve in-hospital mortality and management in patients with acute coronary syndrome?
Odds Ratio: 0.7 (95% CI 0.53–0.93)
Chest pain centre accreditation is associated with significantly lower in-hospital mortality, shorter length of stay, and increased utilization of PCI for patients with acute coronary syndrome.
Sun et al. (2020) conducted an observational in acute coronary syndrome (n=798,008). Chest pain centre (CPC) accreditation vs. Hospitals without CPC accreditation was evaluated on in-hospital mortality (OR 0.70, 95% CI 0.53 to 0.93). Chest pain centre accreditation was associated with lower in-hospital mortality (OR 0.70; 95% CI 0.53-0.93) and increased PCI usage among patients with acute coronary syndrome.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: